HMNC Brain Health
Dr. Christine zu Eulenburg has a diverse work experience in the field of statistics and biostatistics. Dr. Christine started their career as a Promovendus and later became a Postdoc Researcher at Universitätsklinikum Hamburg Eppendorf from 2007 to 2016. Dr. Christine then served as a Visiting Research Fellow at the David Geffen School of Medicine at UCLA for a brief period in 2010. Dr. zu Eulenburg then joined UMCG Universitair Medisch Centrum Groningen as a Full Professor of Medical Statistics from 2016 to 2019. In 2019, they co-founded Syngredient GmbH and simultaneously worked as an Expert Statistician at www.lifesciencestatistics.de, providing statistical consultation for clinical studies and medical diagnostics. In 2020, Dr. zu Eulenburg became the Head of Biostatistics at WSG - Westdeutsche Studiengruppe GmbH and currently holds the position of Senior Director Biostatistics at HMNC Brain Health since 2022.
Dr. Christine zu Eulenburg earned a Diplom degree in Wirtschaftsmathematik from the University of Hamburg, where they studied from 2000 to 2005. Dr. Christine then pursued further education at the same university and obtained a Dr. rer.pol. degree in Wirtschaftswissenschaften from 2005 to 2009. Following this, they attended the Universitätsklinikum Hamburg-Eppendorf from 2009 to 2016, where they achieved a Habilitation degree in Medical Biometry and Epidemiology.
This person is not in any teams
This person is not in any offices
HMNC Brain Health
HMNC Brain Health develops patented genetic tests and combines those with innovative exclusively in-licensed medications, resulting in precise therapies for depression and other neuropsychiatric disorders.Founded in 2010, the privately held biotech company combines the development of machine learning-enabled companion diagnostics with specifictherapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression. The ultimate goal is to improve the lives of patients by developing highly disruptive solutions for their high unmet medical needs. HMNC Brain Health strives to reduce not only the immense individual burden but also the societal impact of these diseases.